Loading...
NPI 1053686964 · North Little Rock, AR · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Advanced Pathology Solutions, PLLC is a clinical medical laboratory provider located in North Little Rock, Arkansas. This profile covers 35 Medicare and 28 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Advanced Pathology Solutions, PLLC |
| Address | 5328 Northshore Cv |
| City | North Little Rock |
| State | AR |
| ZIP | 72118 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | March 12, 2012 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $14.1M |
| Medicaid | $4.6M |
This provider is a high-volume clinical pathology and molecular diagnostic operation: Medicare top codes are led by surgical pathology and special stains (88305: 94.1K claims, $2.6M revenue; 88312: 46.9K claims, $2.3M revenue; 88342: 20K claims, $1.4M revenue) and a large suite of amplified nucleic acid probe tests for infectious agents (e.g., 87798, 87481, 87551). The code mix and descriptions indicate routine surgical pathology interpretation plus extensive molecular infectious testing, consistent with a reference lab that processes both tissue diagnostics and high-volume infectious disease assays for external clinicians.
Revenue concentration is meaningful on both payers: precomputed shares show the top 3 Medicare codes by revenue account for 44.8% of Medicare revenue and the top 3 Medicaid codes by revenue account for 55.3% of Medicaid revenue. For Medicare the dominant trio includes 88305, 88312, and 88342; for Medicaid the dominant trio includes 88312, 88305, and 88313, showing most dollars are tied to a small set of pathology and stain services.
Payer mix is Medicare‑weighted in scale: Total Medicare revenue is $14.1M while Total Medicaid revenue is $4.6M, so the provider’s Medicare business is larger in absolute dollars. Both payers show the same operational focus, but business volume and reimbursement scale are substantially greater on Medicare based on the reported totals.
The provider is a market leader on key codes nationally and in-state: for Medicare 88312 ranks #1 of 6966 providers nationally and is labeled an extreme outlier, 88342 ranks #1 of 11370 (extreme outlier), and 88305 ranks #5 of 14580 (extreme outlier). On Medicaid several of the same codes also rank #1 in-state (88312, 88305, 88313), indicating dominant statewide positioning for core surgical pathology and stain services.
Multiple individual codes are flagged as extreme outliers or notably above typical volume, underscoring unusual scale for specific services: examples include Medicare 88312 (100th percentile; extreme outlier), 88305 (100th percentile; extreme outlier), and Medicaid 88313 (100th percentile; extreme outlier). These labels suggest this provider performs materially more of these specialized pathology and stain procedures than typical peers.
The molecular infectious-testing line is also prominent and shows above-typical volumes: Medicare lists high-volume probe/amplified test codes such as 87481 (18.5K claims, $629.9K revenue; 98th percentile; notably above typical), 87551 (12.7K claims, $598.7K revenue; 100th percentile; extreme outlier), and several 876xx/875xx codes that are 100th‑percentile extreme outliers. Medicaid mirrors this pattern with 87481, 87500, 87551, and 87641 all ranking at or near the top in-state, indicating a substantial infectious-disease molecular testing footprint.
Concentration by a handful of high-volume pathology and stain codes creates operational clarity and exposure: the same surgical pathology/stain codes (88305, 88312, 88313, 88342) drive the majority share of Medicaid and a large share of Medicare revenue, and the top-3 shares (44.8% Medicare, 55.3% Medicaid) highlight dependence on these service lines. For contracting and network decisions this profile points to the provider being a specialist/reference center for tissue diagnostics and high-throughput stain/IHC services rather than a general multispecialty clinic.
Tenure and registration support established operations: the NPI was enumerated on 2012-03-12 (~14 years ago), which combined with sustained multi‑million dollar Medicare ($14.1M) and Medicaid ($4.6M) receipts suggests this is a long-standing laboratory with consistent billing activity across both payers. The sustained high ranks on numerous codes nationally and in-state are consistent with established, volume-driven lab services rather than a new entrant.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
35 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 88305 | The physician, typically a pathologist, performs a level IV examination of a surgical pathology specimen. The examination includes accessioning the specimen into the lab, which involves formally… | 94,060 | $30 | $2.6M |
| 88312 | The lab analyst performs the technical lab steps to stain a specimen with a special stain. This code applies to Group I for microorganisms. A qualified provider, typically a pathologist, interprets… | 46,900 | $50 | $2.3M |
| 88342 | The lab analyst applies an initial single antibody stain on a slide or slides prepared from a single patient specimen, such as tumor tissue. Then a qualified provider, typically a pathologist,… | 19,960 | $70 | $1.4M |
| 88313 | The lab analyst performs the technical lab steps to stain a specimen for Group II identification, for example an iron stain or trichrome stain. A qualified provider, typically a pathologist,… | 49,030 | $20 | $980.6K |
| 87798 | The lab analyst performs a test for an infectious agent not specified in another code using an amplified nucleic acid probe technique. Use this code if you know the laboratory technique is amplified… | 26,680 | $30 | $907K |
| 87481 | The lab analyst performs a test for Candida species using amplified nucleic acid probe technique. | 18,530 | $30 | $629.9K |
| 87551 | The lab analyst performs a test for the presence of Mycobacterium species using amplified nucleic acid probe technique. Mycobacteria are bacteria, sometimes called acid fast bacteria, because of the… | 12,740 | $50 | $598.7K |
| 87506 | The lab analyst performs a test to detect six to eleven types or subtypes of a pathogen, such as Clostridium difficile, E. coli, Salmonella, Shigella, norovirus, Giardia, that cause gastrointestinal… | 2,110 | $260 | $543K |
| 87500 | The lab analyst performs a test for vancomycin resistance in an infectious organism’s nucleic acid using amplified probe technique. VRE, vancomycin resistant enterococcus, is the most common organism… | 13,350 | $30 | $453.9K |
| 87640 | The lab analyst performs the technical lab test to look for Staphylococcus aureus nucleic acid using an amplified probe technique. | 13,350 | $30 | $453.8K |
Showing 1–10 of 35
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 35 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
35 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| 87471 | 1 | 10 | 10,260 | $30 | $351.7K |
| 87551 | 1 | 10 | 6,380 | $50 | $300.8K |
| 87507 | 1 | 10 | 390 | $410 | $160.5K |
| 88356 | 1 | 10 | 870 | $170 | $145.9K |
| 87798 | 3 | 30 | 120 | $30 | $131.4K |
| 87506 | 1 | 10 | 20 | $260 | $90.1K |
| 87801 | 2 | 10 | 20 | $70 | $54.2K |
| 88305 | 1 | 180 | 450 | $30 | $48.1K |
| 87481 | 1 | 30 | 40 | $30 | $39.2K |
| 88312 | 1 | 90 | 60 | $50 | $33.5K |
Showing 1–10 of 35
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
28 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 88312 | The lab analyst performs the technical lab steps to stain a specimen with a special stain. This code applies to Group I for microorganisms. A qualified provider, typically a pathologist, interprets… | 50,490 | $20 | $1.1M |
| 88305 | The physician, typically a pathologist, performs a level IV examination of a surgical pathology specimen. The examination includes accessioning the specimen into the lab, which involves formally… | 51,750 | $20 | $983.3K |
| 88313 | The lab analyst performs the technical lab steps to stain a specimen for Group II identification, for example an iron stain or trichrome stain. A qualified provider, typically a pathologist,… | 47,760 | $10 | $525.3K |
| 88342 | The lab analyst applies an initial single antibody stain on a slide or slides prepared from a single patient specimen, such as tumor tissue. Then a qualified provider, typically a pathologist,… | 27,350 | $10 | $355.6K |
| 87798 | The lab analyst performs a test for an infectious agent not specified in another code using an amplified nucleic acid probe technique. Use this code if you know the laboratory technique is amplified… | 12,430 | $20 | $298.3K |
| 88304 | The physician, typically a pathologist, performs a level III examination of a surgical pathology specimen. The examination includes accessioning the specimen into the lab, which involves formally… | 27,080 | $10 | $270.8K |
| 87481 | The lab analyst performs a test for Candida species using amplified nucleic acid probe technique. | 18,700 | $10 | $187K |
| 88311 | The lab analyst performs a decalcification procedure on a specimen. Dissolving the calcium makes it easier to perform certain examinations. | 27,200 | $1 | $108.8K |
| 87500 | The lab analyst performs a test for vancomycin resistance in an infectious organism’s nucleic acid using amplified probe technique. VRE, vancomycin resistant enterococcus, is the most common organism… | 15,120 | $10 | $105.8K |
| 87551 | The lab analyst performs a test for the presence of Mycobacterium species using amplified nucleic acid probe technique. Mycobacteria are bacteria, sometimes called acid fast bacteria, because of the… | 12,120 | $10 | $96.9K |
Showing 1–10 of 28
How this provider's Medicaid billing volume and revenue compare to other Arkansas providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Arkansas median
28 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 87798 | The lab analyst performs a test for an infectious agent not specified in another code using an amplified nucleic acid probe technique. Use this code if you know the laboratory technique is amplified… | 3 | 30 | 160 | $70 | $259.6K |
| 88305 | The physician, typically a pathologist, performs a level IV examination of a surgical pathology specimen. The examination includes accessioning the specimen into the lab, which involves formally… | 1 | 90 | 510 | $40 | $105.7K |
| 87551 | The lab analyst performs a test for the presence of Mycobacterium species using amplified nucleic acid probe technique. Mycobacteria are bacteria, sometimes called acid fast bacteria, because of the… | 1 | 10 | 12,120 | $10 | $101.7K |
| 87651 | The lab analyst performs a test for the bacteria Streptococcus, group A, using amplified nucleic acid probe technique. Strep A commonly causes acute pharyngitis, or strep throat. | 4 | 110 | 600 | $40 | $95.8K |
| 88313 | The lab analyst performs the technical lab steps to stain a specimen for Group II identification, for example an iron stain or trichrome stain. A qualified provider, typically a pathologist,… | 1 | 20 | 810 | $20 | $73.9K |
| 88346 | The analyst performs an immunofluorescent study using a single antibody stain procedure to detect autoimmune disease or an infectious organism in a tissue or cellular sample. | 3 | 10 | 170 | $20 | $59.5K |
| 88356 | After a lab analyst prepares slides, the qualified provider, typically a pathologist, performs a morphometric analysis to evaluate size, shape, and other physical features of a nerve. | 1 | 10 | 860 | $60 | $53.6K |
| 88312 | The lab analyst performs the technical lab steps to stain a specimen with a special stain. This code applies to Group I for microorganisms. A qualified provider, typically a pathologist, interprets… | 1 | 30 | 460 | $20 | $45.6K |
| 88341 | The lab analyst applies an additional single antibody stain on a slide or slides prepared from the same patient specimen as the initial antibody stain, such as tumor tissue. Then a qualified… | 2 | 20 | 190 | $70 | $40.5K |
| 87471 | The lab analyst performs a test for Bartonella henselae and Bartonella quintana using amplified nucleic acid probe technique. | 1 | 10 | 5,600 | $10 | $38.4K |
Showing 1–10 of 28
Other providers in the same ZIP code as Advanced Pathology Solutions, PLLC, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Med South Medical Inc | AR | Parenteral & Enteral Nutrition Supplies (DME) | $0 | $21M |
| Orthotics At Home, Inc | AR | Customized Equipment (DME) | $0 | $10.9M |
| Infinite Genomics LLC | AR | Clinical Medical Laboratory | $1.9M | $2M |
| Scalia Otr/l, Inc. | AR | Occupational Therapist | $0 | $3.8M |
| Alptp, PLLC | AR | Pediatric Occupational Therapist | $0 | $2.7M |
| William Bowen | AR | Orthopaedic Surgery Physician | $530.8K | $0 |
| Paul Edwards | AR | Adult Reconstructive Orthopaedic Surgery Physician | $369.2K | $0 |
| William Hefley | AR | Orthopaedic Surgery Physician | $357.8K | $0 |
| Brad Thomas | AR | Neurological Surgery Physician | $352.9K | $0 |
| Samuel Moore | AR | Orthopaedic Surgery Physician | $331.5K | $1.6K |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.